UK Markets closed

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
909.00-47.00 (-4.92%)
At close: 04:37PM GMT
Full screen
Previous close956.00
Bid0.00 x 0
Ask1,560.00 x 0
Day's range905.00 - 955.00
52-week range905.00 - 1,678.00
Avg. volume165,999
Market cap783.332M
Beta (5Y monthly)0.78
PE ratio (TTM)41.13
EPS (TTM)22.10
Earnings date13 Apr 2022 - 18 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1,810.86

    1 UK stock I’d buy in 2022 to try to double my money

    With UK stocks on the rise in 2022, Zaven Boyrazian shares his top pick from his own portfolio that could deliver triple-digit returns. The post 1 UK stock I’d buy in 2022 to try to double my money appeared first on The Motley Fool UK.

  • Globe Newswire

    John Dawson to retire from Oxford Biomedica

    John Dawson to retire from Oxford Biomedica Oxford, UK – 17 January 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group” or “the Company”) a leading gene and cell therapy company, today announces that, after more than 13 years of service, John Dawson, Chief Executive Officer, has signalled to the Board his intention to retire from the Company. Accordingly, the Board has initiated a formal search for a successor. Dr. Roch Doliveux, Chairman of Oxford Biomedica, commented: “John

  • Simply Wall St.

    What Type Of Shareholders Own The Most Number of Oxford Biomedica plc (LON:OXB) Shares?

    Every investor in Oxford Biomedica plc ( LON:OXB ) should be aware of the most powerful shareholder groups. Insiders...